NO996161L - En kontrollert frigjoerende formulering for tungt loeselige basiske legemidler - Google Patents
En kontrollert frigjoerende formulering for tungt loeselige basiske legemidlerInfo
- Publication number
- NO996161L NO996161L NO996161A NO996161A NO996161L NO 996161 L NO996161 L NO 996161L NO 996161 A NO996161 A NO 996161A NO 996161 A NO996161 A NO 996161A NO 996161 L NO996161 L NO 996161L
- Authority
- NO
- Norway
- Prior art keywords
- controlled release
- release formulation
- soluble basic
- basic drugs
- heavily soluble
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO996161A NO310095B1 (no) | 1997-06-11 | 1999-12-13 | En kontrollert frigjørende formulering for tungt løselige basiske legemidler |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1997/010705 WO1998056357A1 (en) | 1995-12-19 | 1997-06-11 | A controlled release formulation for poorly soluble basic drugs |
NO996161A NO310095B1 (no) | 1997-06-11 | 1999-12-13 | En kontrollert frigjørende formulering for tungt løselige basiske legemidler |
Publications (3)
Publication Number | Publication Date |
---|---|
NO996161L true NO996161L (no) | 1999-12-13 |
NO996161D0 NO996161D0 (no) | 1999-12-13 |
NO310095B1 NO310095B1 (no) | 2001-05-21 |
Family
ID=22261117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO996161A NO310095B1 (no) | 1997-06-11 | 1999-12-13 | En kontrollert frigjørende formulering for tungt løselige basiske legemidler |
Country Status (4)
Country | Link |
---|---|
NO (1) | NO310095B1 (no) |
SI (1) | SI20108B (no) |
SK (1) | SK282427B6 (no) |
WO (1) | WO1998056357A1 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3668000A (en) * | 1999-04-29 | 2000-11-17 | Russinsky Limited | Compounds |
EP1118333A1 (en) * | 2000-01-18 | 2001-07-25 | Eurand International S.P.A. | Compositions with enhanced oral bioavailability |
UA76967C2 (uk) * | 2000-11-27 | 2006-10-16 | Сандоз Аг | Азитроміцин у формі моногідрату, фармацевтична композиція та спосіб його одержання |
WO2003082248A2 (en) * | 2002-04-03 | 2003-10-09 | Ranbaxy Laboratories Limited | Taste masked compositions of erythromycin a and derivatives thereof |
SI21300A (sl) * | 2002-10-08 | 2004-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Farmacevtske formulacije z alginati |
CN100336511C (zh) * | 2002-11-15 | 2007-09-12 | 江苏豪森药业股份有限公司 | 口服罗红霉素控释制剂 |
EP1638529B1 (en) * | 2003-06-16 | 2016-08-10 | ANDRX Pharmaceuticals, LLC. | Oral extended-release composition |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60163823A (ja) * | 1984-02-03 | 1985-08-26 | Taisho Pharmaceut Co Ltd | 経口投与製剤 |
ATE66143T1 (de) * | 1985-01-11 | 1991-08-15 | Abbott Lab | Feste zubereitung mit langsamer freisetzung. |
US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
-
1997
- 1997-06-11 SI SI9720096A patent/SI20108B/sl unknown
- 1997-06-11 SK SK1612-99A patent/SK282427B6/sk not_active IP Right Cessation
- 1997-06-11 WO PCT/US1997/010705 patent/WO1998056357A1/en active Application Filing
-
1999
- 1999-12-13 NO NO996161A patent/NO310095B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SI20108B (en) | 2001-12-31 |
SI20108A (sl) | 2000-06-30 |
NO310095B1 (no) | 2001-05-21 |
SK282427B6 (sk) | 2002-01-07 |
SK161299A3 (en) | 2000-05-16 |
WO1998056357A1 (en) | 1998-12-17 |
NO996161D0 (no) | 1999-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL121275A0 (en) | A controlled release formulation for poorly soluble basic drugs | |
MA26576A1 (fr) | Formulation pharmaceutique orale a liberation prolongee | |
MA26577A1 (fr) | Formulation pharmaceutique orale a liberation pulsee | |
NO20000735D0 (no) | Legemiddel leveringsanordning for vedvarende frigivelse | |
ATE234078T1 (de) | Pharmazeutische omeprazol-formulierung | |
EE04294B1 (et) | Farmatseutiline kompositsioon piperidinoalkanooldekongestandi kombineerimiseks | |
EP1124543A4 (en) | REGULATED RELEASE FORMULATION FOR WATER-SOLUBLE DRUGS | |
FIU20000164U0 (fi) | Uusi farmaseuttinen formulaatio | |
EE200000361A (et) | Seade ravimit sisaldava vedeliku manustamiseks | |
DE69904312D1 (de) | Pharmazeutische aerosolformulierung | |
BR9607752B1 (pt) | formulação farmacêutica de microcápsula de liberação controlada. | |
ZA982872B (en) | Pharmaceutical formulation | |
NO996161D0 (no) | En kontrollert frigjoerende formulering for tungt loeselige basiske legemidler | |
NO20002126L (no) | Formulering med forlenget frigjøring | |
NO20001375D0 (no) | Legemiddelformulering med kontrollert virkestoffrigivning | |
HK1045465A1 (en) | A pharmaceutical formulation comprising megalatranand its prodrug | |
PT868911E (pt) | Formulacoes de rapamicina para administracao oral | |
EE9900545A (et) | Farmatseutiline kompositsioon | |
NO996044L (no) | Rapamycinformuleringer for oral administrasjon | |
GB9709739D0 (en) | Pharmaceutical formulation | |
NO980072D0 (no) | Opplösbar frigjöringsmekanisme for bevegelige skjöter | |
HRP970325B1 (en) | Controlled release formulation for poorly soluble basic drugs | |
GB9724175D0 (en) | A pharmaceutical formulation | |
GB9720099D0 (en) | Pharmaceutical salts | |
FI3862U1 (fi) | Geelimuotoinen farmaseuttinen valmiste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: BGP PRODUCTS OPERATIONS GMBH, CH |
|
MK1K | Patent expired |